January 7, 2026
Poplar Therapeutics
Poplar Therapeutics anti-IgE therapy treats atopic diseases...
- Round
- Series A
- Amount raised
- $50M
- Lead investor
- Platanus
- Industry
- Health Care
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1-10
- Website
- poplartx.com
- —
Other investors
- SR One
- Vida Ventures